Cargando…
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993725/ https://www.ncbi.nlm.nih.gov/pubmed/34705134 http://dx.doi.org/10.1007/s10637-021-01192-5 |
| _version_ | 1784683961248645120 |
|---|---|
| author | Thein, Kyaw Zin Piha-Paul, Sarina A. Tsimberidou, Apostolia Karp, Daniel D. Janku, Filip Zarifa, Abdulrazzak Shah, Jatin Milton, Denái R. Bean, Stacie McQuinn, Lacey Gong, Jing Colen, Rivka Carter, Brett W. Subbiah, Vivek Ogbonna, Deby C. Pant, Shubham Meric-Bernstam, Funda Naing, Aung |
| author_facet | Thein, Kyaw Zin Piha-Paul, Sarina A. Tsimberidou, Apostolia Karp, Daniel D. Janku, Filip Zarifa, Abdulrazzak Shah, Jatin Milton, Denái R. Bean, Stacie McQuinn, Lacey Gong, Jing Colen, Rivka Carter, Brett W. Subbiah, Vivek Ogbonna, Deby C. Pant, Shubham Meric-Bernstam, Funda Naing, Aung |
| author_sort | Thein, Kyaw Zin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8993725 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89937252022-04-22 Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study Thein, Kyaw Zin Piha-Paul, Sarina A. Tsimberidou, Apostolia Karp, Daniel D. Janku, Filip Zarifa, Abdulrazzak Shah, Jatin Milton, Denái R. Bean, Stacie McQuinn, Lacey Gong, Jing Colen, Rivka Carter, Brett W. Subbiah, Vivek Ogbonna, Deby C. Pant, Shubham Meric-Bernstam, Funda Naing, Aung Invest New Drugs Correction Springer US 2021-10-27 2022 /pmc/articles/PMC8993725/ /pubmed/34705134 http://dx.doi.org/10.1007/s10637-021-01192-5 Text en © ©The Author(s) 2021 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Thein, Kyaw Zin Piha-Paul, Sarina A. Tsimberidou, Apostolia Karp, Daniel D. Janku, Filip Zarifa, Abdulrazzak Shah, Jatin Milton, Denái R. Bean, Stacie McQuinn, Lacey Gong, Jing Colen, Rivka Carter, Brett W. Subbiah, Vivek Ogbonna, Deby C. Pant, Shubham Meric-Bernstam, Funda Naing, Aung Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study |
| title | Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study |
| title_full | Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study |
| title_fullStr | Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study |
| title_full_unstemmed | Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study |
| title_short | Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study |
| title_sort | correction to: selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: results of an open-label, single-center, multi-arm phase ib study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993725/ https://www.ncbi.nlm.nih.gov/pubmed/34705134 http://dx.doi.org/10.1007/s10637-021-01192-5 |
| work_keys_str_mv | AT theinkyawzin correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT pihapaulsarinaa correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT tsimberidouapostolia correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT karpdanield correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT jankufilip correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT zarifaabdulrazzak correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT shahjatin correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT miltondenair correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT beanstacie correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT mcquinnlacey correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT gongjing correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT colenrivka correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT carterbrettw correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT subbiahvivek correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT ogbonnadebyc correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT pantshubham correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT mericbernstamfunda correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy AT naingaung correctiontoselinexorincombinationwithtopotecaninpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphaseibstudy |